Children and adolescents treated with fremanezumab experienced fewer migraine and headache days compared with placebo, according to an abstract presented at the American Academy of Neurology Annual ...

ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025 ...

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...

Microplastics discovered in life-threatening arterial plaque are associated with strokes. A new study found altered gene ...

A transportation study showed that over 50% of commuters into Aspen come from Basalt or further downvalley. The city of Aspen ...

The study commission will put forth recommendations for Butte-Silver Bow's government structure based on its research that will be voted on in November 2026.

The full text of the abstract will be released by ASCO on May 22, 2025, at 5:00 PM EDT on asco.org/abstracts.

Ivonescimab plus chemotherapy improved survival in advanced squamous NSCLC vs tislelizumab and chemotherapy in a phase 3 trial.

A packed house Monday night in Danville was urged to educate themselves about the dangers of wind turbines on humans, ...

A new study shows that the brain's visual system adapts to your goals, reshaping perception based on what you're trying to do ...

We are looking to defer building of that sidewalk and some of the curbing until that road is widened, but we’re going to ...

The Department of Justice is investigating L.A. County over alleged waits of up to 18 months for gun permits, a case that ...